These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35316889)

  • 1. Clinical impact of spine magnetic resonance imaging as a valuable prognostic tool for patients with multiple myeloma: a retrospective study.
    Lee JM; Cho HJ; Moon JH; Sohn SK; Park B; Baek DW
    J Yeungnam Med Sci; 2022 Oct; 39(4):300-308. PubMed ID: 35316889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
    Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
    Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
    Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Raab MS; Hillengass M; Wagner B; Jauch A; Hose D; Weber MA; Delorme S; Goldschmidt H; Hillengass J
    Haematologica; 2015 Jun; 100(6):818-25. PubMed ID: 25795721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.
    Sun M; Cheng J; Ren C; Zhang Y; Li Y; Li Y; Zhang S
    Quant Imaging Med Surg; 2021 Aug; 11(8):3767-3780. PubMed ID: 34341748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.
    Moulopoulos LA; Gika D; Anagnostopoulos A; Delasalle K; Weber D; Alexanian R; Dimopoulos MA
    Ann Oncol; 2005 Nov; 16(11):1824-8. PubMed ID: 16087694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
    Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
    Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of the revised international staging system for newly diagnosed multiple myeloma patients].
    Lu J; Du J; Fu WJ; He HY; Li L; Li R; Zhou LL; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):475-479. PubMed ID: 28655089
    [No Abstract]   [Full Text] [Related]  

  • 11. Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
    Song MK; Chung JS; Lee JJ; Min CK; Ahn JS; Lee SM; Shin DY; Bae SH; Hong J; Lee GW; Lee IS; Shin HJ
    Br J Haematol; 2014 Jun; 165(6):777-85. PubMed ID: 24628463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification model in elderly patients with multiple myeloma: clinical role of magnetic resonance imaging combined with international staging system and cytogenetic abnormalities.
    Song MK; Chung JS; Lee JJ; Lee JH; Song IC; Lee SM; Shin DY; Lee GW; Lee IS
    Acta Haematol; 2015; 134(1):7-16. PubMed ID: 25832367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infiltration patterns of plasmacytomas in magnetic resonance tomography].
    Baur A; Stäbler A; Bartl R; Lamerz R; Reiser M
    Rofo; 1996 Jun; 164(6):457-63. PubMed ID: 8688501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
    Gopalakrishnan S; D'Souza A; Scott E; Fraser R; Davila O; Shah N; Gale RP; Kamble R; Diaz MA; Lazarus HM; Savani BN; Hildebrandt GC; Solh M; Freytes CO; Lee C; Kyle RA; Usmani SZ; Ganguly S; Assal A; Berdeja J; Kanate AS; Dhakal B; Meehan K; Kindwall-Keller T; Saad A; Locke F; Seo S; Nishihori T; Gergis U; Gasparetto C; Mark T; Nieto Y; Kumar S; Hari P
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):683-688. PubMed ID: 30579965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
    Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
    Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnosis of plasmocytoma with MRT].
    Baur A
    Radiologe; 2000 Aug; 40(8):716-22. PubMed ID: 11006942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
    Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
    Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].
    Baur-Melnyk A; Reiser M
    Radiologe; 2004 Sep; 44(9):874-81. PubMed ID: 15365631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.